Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
PDS Biotechnology Corporation (PDSB) had Operating Cash Flow per Share of $-0.51 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-9.01M |
|
-- |
|
-- |
|
$8.14M |
|
$-8.14M |
|
$-0.87M |
|
$-9.01M |
|
$-9.01M |
|
$-9.01M |
|
$-9.01M |
|
$-9.01M |
|
$-9.01M |
|
$-8.14M |
|
$-8.43M |
|
46.87M |
|
46.87M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$27.89M |
|
$0.13M |
|
$6.81M |
|
$34.71M |
|
$13.33M |
|
$11.92M |
|
$11.92M |
|
$25.25M |
|
$9.45M |
|
$9.45M |
|
$9.45M |
|
47.70M |
|
| Cash Flow Statement Financials | |
$-24.05M |
|
-- |
|
$8.56M |
|
$41.69M |
|
$26.20M |
|
$-15.49M |
|
$2.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.09 |
|
-- |
|
-- |
|
0.56 |
|
1.90 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-24.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-95.30% |
|
-95.30% |
|
-25.96% |
|
-42.15% |
|
$0.20 |
|
$-0.51 |
|
|
Operating Cash Flow per Share |
$-0.51 |